The latest report by IMARC Group, titled “Protein Detection & Quantification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global protein detection & quantification market size reached US$ 2.50 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.40 Billion by 2028, exhibiting a growth rate (CAGR) of 9.2% during 2023-2028.

Protein detection & quantification are fundamental processes in life sciences, essential for understanding various biological phenomena. Protein detection refers to identifying and confirming the presence of specific proteins within a biological sample, which can be achieved through techniques such as Western blotting, enzyme-linked immunosorbent assays (ELISA), or mass spectrometry. Protein quantification involves determining the amount or concentration of a particular protein in a sample. Accurate quantification is essential for studying protein expression levels, tracking changes in response to different conditions, or evaluating the efficacy of treatments or interventions. Common methods for protein quantification include the Bradford assay, bicinchoninic acid (BCA) assay, and quantitative mass spectrometry. Nowadays, protein detection and quantification are essential in molecular biology, clinical diagnostics, and drug development.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/protein-detection-quantification-market/requestsample

Protein Detection & Quantification Market Trends and Drivers:

The market of protein detection & quantification is driven by the growing biopharmaceutical industry that relies on protein detection and quantification techniques for drug discovery, development, and manufacturing. In addition, the continuous development of biologics and biosimilars is escalating the demand for accurate and efficient protein analysis methods, thus influencing market growth. Moreover, several innovations in detection technologies, such as mass spectrometry, immunoassays, and fluorescence-based methods, are improving the sensitivity and accuracy of protein analysis, which made it easier to detect and quantify proteins at low concentrations, thus representing another major growth-inducing factor. Besides this, the rising food and beverage industry uses protein detection methods to ensure product quality and safety, thus accelerating the sales demand. Along with this, the increasing use of protein detection and quantification in clinical diagnostics aids in the early detection of diseases and monitoring treatment responses, resulting in the integration of protein analysis into clinical laboratories and healthcare settings is propelling the market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Kits and Reagents/Consumables
  • Instruments
  • Services

 

Breakup by Technology:

  • Colorimetric Assays
  • Immunological Methods
  • Chromatography
  • Mass Spectrometry
  • Spectroscopy Instruments
  • Others

 

Breakup by Application:

  • Drug Discovery and Development
  • Clinical Diagnosis
  • Others

 

Breakup by End User:

  • Academic Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organization
  • Others

 

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

 

Competitive Landscape with Key Player:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • General Electric Company
  • Inanovate Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • RayBiotech Life Inc. 
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

 

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal